Korea South
Daewon Pharmaceutical is a seasoned player in the pharmaceutical industry, with a rich history dating back to its establishment in 1958. Boasting the slogan "Building a healthier future with innovative pharmaceuticals since 1958," the company has remained true to its commitment to enhancing human health for over six decades. Through unwavering dedication to research and development, they have achieved significant milestones, most notably with the creation of Pelubi, their 12th new drug in Korea.
Operating within the Biotechnology, Health Care, Manufacturing, and Pharmaceutical sectors, Daewon Pharmaceutical has consistently adapted to contemporary environmental changes while maintaining its status as a professional pure drug company. With their core principle centered around prioritizing health and happiness, the company continues to contribute to the well-being of people by continuously developing new and improved drug pipelines.
Whilst the exact details of their headquarters and last investment remain undisclosed, the company's track record and commitment to innovation make them an intriguing prospect for potential investors looking to tap into the pharmaceutical and healthcare sectors.
